Chemotactic peptides, such as Monocyte Chemotactic Protein 1 (MCP-1), play a key role in transendothelial migration of mononuclear cells during the development and progression of atherosclerotic disease. Because atherosclerotic plaques that are precursors of acute coronary events harbor abundant macrophage infiltration, we hypothesized that the detection of a high concentration of MCP-1 receptors on inflammatory cells should noninvasively identify vulnerable plaques. Methods: Atherosclerotic lesions were induced by balloon deendothelialization of the abdominal aorta, which was followed by a 0.5% cholesterol diet for 16 wk in 7 New Zealand White rabbits; 5 unmanipulated rabbits, fed normal chow for 16 wk, were used as controls. Radionuclide imaging was performed immediately after intravenous 99m Tc-labeled MCP-1 administration and 3 h later. At the end of imaging session, aortas were explanted and submitted for estimation of quantitative MCP-1 uptake (in percentage injected dose per gram, %ID/g) and pathologic characterization. Results: Atherosclerotic lesions were clearly visible in all hyperlipidemic animal g-imaging. No tracer uptake was seen in the control rabbits. The mean quantitative MCP-1 uptake in atherosclerotic lesions was 4-fold higher than that of the aortic specimens from the control rabbits (0.065 6 0.005 vs. 0.016 6 0.006; P , 0.0001). Histology confirmed a strong correlation between MCP-1 uptake and the number of macrophages in American Heart Association type II2IV lesions (r 5 0.87, P , 0.0001). Conclusion: Noninvasive radionuclide imaging of inflammation is feasible by MCP-1 in experimentally induced atherosclerosis. It is proposed that detection of the extent of inflammation in advanced atherosclerotic plaques may allow identification of unstable plaques.
Chemoki nes or chemotactic cytokines play a critical role in the inflammatory process in development and progression of atherosclerosis (1) . Monocyte recruitment into the arterial wall in response to injury is a multistep process that involves reversible adhesion of monocytes to the endothelium, activation of monocytes, firm adherence, and, finally, migration to the subendothelial space through endothelial cell junctions (2) (3) (4) . Monocyte Chemotactic Protein 1 (MCP-1) is overexpressed at the site of inflammation and mediates the transendothelial migration of mononuclear cells via CC chemokines receptor 2 (CCR-2) receptors expressed at their cell surface (4) (5) (6) . In the hyperlipidemic state, activation of the MCP-1/CCR-2 pathway also induces adhesion molecules, proinflammatory cytokines, and chemokines and, thus, accelerates atherosclerosis (7) (8) (9) . The early expression of MCP-1 by smooth muscle cells (SMC) and endothelial cells is responsible for the initial influx of monocytes into the vessel wall. The recruited monocytes/macrophages start to express MCP-1, triggering the continuing infiltration of macrophages in the neointima, suggesting a key role of MCP-1 in the progression of atherosclerosis.
Proinflammatory cytokines such as interleukin 1 (IL-1), interferon-g (INF-g), and tumor necrosis factor-a (TNF-a) are known to increase the levels of CC chemokines (10) . Other chemokines, produced at the site of inflammation, such as IL-1, TNF-a, INF-g (10) , RANTES (regulated on activation, T-cell expressed and secreted), MIP-1a and -b (macrophage inflammatory proteins a and b) (11, 12) or, more recently discovered MCP-4, ELC (EBI 1 ligand chemokine), PARC (pulmonary and activation regulated cytokine) (13) , and IL-8 may also subsist as chemoattractants (10, 14) in atherogenesis and vascular remodeling (15, 16) . MIP-1a and -b, RANTES, and MCP-4 are T-cell chemoattractants expressed in the more advanced atherosclerotic lesion (13) . Unlike them, PARC has a specificity to attract naïve, resting T-cells, and IL-8 facilitates a firm adhesion of monocytes to endothelium. Monocytes, once resident within the subintimal layer, transform to macrophages and eventually develop into foam cells by internalizing oxidized low-density lipoprotein (LDL) mediated by expression of scavenger receptors (1) .
MCP-1 is a low-molecular-weight (9-15 kDa) monomeric peptide (17) , which is predominantly expressed by endothelial cells (18, 19) and macrophages (20) . Vascular injury leads to selective MCP-1 expression on the endothelial cells or secretion of soluble MCP-1 (21) . Circulating MCP-1 facilitatesin addition to monocyte migration and activation-upregulation of the MCP-1/CCR-2 receptors for this peptide. Because MCP-1 receptor is predominantly expressed by infiltrating macrophages, we hypothesized that radiolabeled MCP-1 should help target MCP-1 receptor-bearing cells in atherosclerotic lesions for noninvasive imaging. Because inflammation is one of the most important determinants of plaque vulnerability, it is expected that imaging of inflammation would allow development of preventive strategies.
MATERIALS AND METHODS

Radiolabeling of MCP-1
Recombinant human MCP-1, expressed in Escherichia coli, was derivatized with the nicotinic acid analog hydrazinonicotinamide (HYNIC; Theseus Imaging Corp.). Each vial of HYNIC-MCP-1 provided by Theseus Imaging contained 40 mM ammonium acetate and 100 mM tricine, pH 6. For radiolabeling, 50-100 mL of 99m Tclabeled sodium pertechnetate (1,110 MBq [30 mCi]) were added to the protein vial. Then, 1 mL of 0.9% sodium chloride solution was added to the stannous tricine vial, and the vial was gently swirled until the lyophilized contents were dissolved. Immediately after dissolving, 20 mL were withdrawn from the stannous tricine solution and added to the protein vial. After a 30-min incubation at room temperature, instant thin-layer chromatography was performed and the radiopurity of .95%.
MCP-1 Receptor Expression on Macrophages and Binding of Radiolabeled MCP-1
The radiolabeled MCP-1 was incubated with THP-1 monocytes (human monocytic leukemia cell line) and SMC cultured from the median layer of the aorta of New Zealand White (NZW) rabbits in minimum essential medium/20% fetal calf serum. SMC of passages 3-5 were used for the experiment. For the binding assay, 6 · 10 5 cells per well (THP-1; SMC) were placed in 12-well culture plates. Phorbol 12-myristate 13-acetate (PMA; 10 ng/mL) was added to half of the THP-1 and SMC wells and incubated overnight to activate the cells. For controls, PMAwas not added to the remaining half of the THP-1 and SMC wells. Cells were washed and resuspended in serum-free medium, which was followed by addition of 99m Tc-labeled MCP-1 in a final volume of 1 mL. After incubation for 15 min, 1 h, and 4 h at 37°C, wells were washed 3 times with phosphate-buffered saline (PBS)/bovine serum albumin (BSA). Cells were solubilized with 1 mL of 0.1% sodium dodecyl sulfate in H 2 O and counted for radioactivity in an automatic Wallace g-counter (Perkin Elmer Wallace Inc.); data were expressed as counts per minute (cpm).
Animal Model of Atherosclerosis
Of the total of 12 rabbits included in this study, atherosclerotic lesions were experimentally induced in 7 by deendothelialization of the abdominal aorta, which was followed by a high-cholesterol diet. The remaining 5 unmanipulated rabbits were fed normal rabbit chow for 16 wk and used as control animals.
For the induction of atherosclerotic lesions, male NZW rabbits (2.5-3.5 kg; Millbrook Breeding Laboratories) were started on a high-cholesterol diet containing 0.5% cholesterol and 6% peanut oil 1 wk before deendothelialization of the abdominal aorta as described previously (22) . After anesthesia with a mixture of ketamine and xylazine (100 mg/mL, 10:1 [v/v]; 1.5-2.5 mL subcutaneously), the right femoral artery was surgically exposed. A 4-French Fogarty embolectomy catheter (12-040-4F; Edwards Lifesciences LLC) was introduced through an arteriotomy site, advanced in the aorta up to the level of the diaphragm, inflated to a pressure of 3 psi, and pulled antegrade to the bifurcation of the aorta for endothelial denudation. Three such passes were made. After removing the catheter, the femoral artery was ligated, the incision site was closed, and the animals were returned to cages. The high-cholesterol, highfat diet was continued for an additional 15 wk. This protocol conforms to the Guide for the Care and Use of Laboratory Animals by the U.S. National Institutes of Health (NIH Publication no. 85-23, revised 1996) and has been approved by the Institutional Laboratory Animal Care and Use Committee.
Noninvasive Imaging Using 99m Tc-MCP-1
99m Tc-MCP-1 (333 6 44 MBq) was administered intravenously in all rabbits. Images in the left lateral decubitus position were obtained immediately and 1, 2, and 3 h after the administration of the radioligand using a g-camera (Vertex PLUS; ADAC Laboratories) equipped with a low-energy, parallel-hole collimator. The images were acquired, centered at the 140-keV photopeak of 99m Tc with a symmetric 15% window using a 128 · 128 matrix, as described previously (23) . Planar images of the whole rabbits were obtained for 15 min. After imaging, animals were sacrificed with an overdose of sodium pentobarbital (120 mg/kg). The aortas were harvested and the explanted aortas were imaged for 30 min by laying flat on the g-camera. Aortas were then segmented at 1-cm intervals and weighed; radioactivity was counted in an automatic well-type g-counter (Perkin Elmer Wallace Inc.) for calculation of the percentage total injected dose per gram tissue (%ID/g). Aortas were then preserved for histologic and immunohistochemical investigations. Tissue samples of lungs, heart, liver, spleen, kidneys, and stomach were also harvested, rinsed in saline, weighed, and g-counted, and the results were expressed as the percentage injected dose per gram tissue (%ID/g).
Histolopathogic Characterization of Atherosclerotic Lesions
As described earlier (22) , one half of every aortic segment was snap frozen and the other half was fixed with N-(2-hydroxyethyl) piperazine-N9-(2-ethanesulfonic acid) (HEPES)-buffered 4% formalin for paraffin embedding and further processing. The tissue was then dehydrated in a graded series of ethanol. Each segment was subdivided into 3 equidistant sections and embedded on-edge in paraffin. Serial 4-mm-thick sections were cut and mounted on charged slides (Superfrost; Fisher). Tissue sections were stained with hematoxylin and eosin and Movat pentachrome elastin stain. Atherosclerotic lesions were characterized according to criteria established by the American Heart Association (AHA); only type II-IV lesions were observed (24) (25) (26) .
Immunohistochemistry was performed by standard staining procedures as described previously (22) . Briefly, for cellular charjnm043463-tp n 10/16/07 acterization, sections were deparaffinized in xylene and treated with 0.3% hydrogen peroxide for 20 min to inactivate endogenous peroxides. Tissue sections were then incubated in a protein-free block (Dako) (10 min) to inhibit the nonspecific binding of primary antibody. SMC were identified using a primary antibody against a-actin isotypes (HHF, 1:20, overnight; Enzo), and macrophages were localized using the marker RAM-11 (Dako) (1:200, 1 h). In addition, the MCP-1 antibody (PharMinger, 1:10, overnight; Becton Dickinson Co.) was used for characterization of endogenous and exogenous MCP-1 localization. Primary antibodies were targeted with a biotinylated link antibody directed against mouse immunoglobulin using a peroxidase-based kit (LSAB; Dako). Immunostains were visualized (red-reaction product) by a 3-amino-9-ethyl carbazole (AEC) substrate-chromogen system (Dako) and counterstained with Gill's hematoxylin. The specificity of primary antibody was confirmed both by omitting the primary antibody and by substituting isotype-matched nonspecific antibodies. Immunostaining was observed under an Axiovert-200 inverted microscope (Carl Zeiss), and images were acquired with a Zeiss Axiocam high-resolution digital color camera (1,300 · 1,030 pixels) using Axiovision 3.1 software. Digital images were analyzed using Image-pro Plus Version 5.0 software (Media Cybernetics). The percentage of immunopositive area (immunopositive area/total image area ·100) was determined for all of the markers studied by averaging several images per section that covered most-to-all of the plaque regions. All quantitative comparisons for a given marker were performed on sections stained simultaneously per group. Digital images were obtained using the same settings, and the segmentation parameters were constant within a range for a given marker and experiment.
Statistical Analysis
All results are expressed as the mean 6 SD. To determine the statistical significance of differences between 2 groups, comparisons were made with a 2-tailed Student t test for unpaired data. A P value , 0.05 was considered to be statistically significant.
RESULTS
Ligand-Binding Analyses
SMC formed a single cell layer attached to the well surface. On the other hand, THP-1 cells grew in cell suspension but attached to the well surface on PMA activation. After incubation of 99m Tc-MCP-1 with THP-1 and SMC cells, and PMA-treated THP-1 cells for 15 min, 1 h, and 4 h, radioactivity was counted. MCP-1 uptake in the untreated THP-1 cells (20,493 6 256 cpm) was significantly higher than that of SMC (10,312 6 266 cpm) at 4 h (P 5 0.007) ( ½Fig: 1 Fig. 1 ). PMA-treated THP-1 cells demonstrated a 2-fold increase in MCP-1 uptake at 4 h (43,988 6 1,084 cpm; P , 0.003).
Radionuclide Imaging of Atherosclerotic Lesions
By noninvasive g-imaging, the abdominal atherosclerotic lesions were visualized best by 3 h in hyperlipidemic rabbits ( ½Fig: 2 Fig. 2 ). The uptake was predominantly localized to the infradiaphragmatic aorta. No uptake was seen in the unmanipulated control animals. The %ID/g uptake of the radioligand confirmed the imaging results (Fig. 2) . The quantitative MCP-1 uptake was significantly higher in the lesion areas of the abdominal aorta in atherosclerotic rabbits compared with that of the abdominal aortic segments of unmanipulated animals (0.065 6 0.005 vs. 0.016 6 0.006; P , 0.0001). The MCP-1 accumulation in atherosclerotic lesions was 4-fold higher than that of the corresponding abdominal aortic region of the control animals. The biodistribution of 99m Tc-MCP-1 in nontarget organs was maximum in renal cortex (3.34 6 0.75), spleen (0.39 6 0.14), and liver 0.12 6 0.04) Radiation burden was evident in lung tissue (0.07 6 0.01) and myocardium (0.04 6 0.01).
Histologic and Immunhistochemical Characteristics
The atherosclerotic lesions of the hyperlipidemic animals were classified primarily as AHA type II-IV lesions (24) (25) (26) . The lesions with the highest MCP-1 uptake showed an intense subintimal macrophage accumulation, contained only few smooth muscle cells, and showed low collagen content ( ½Fig: 3 Fig. 3 ). These lesions were predominantly classified as AHA type IV lesions. A strong correlation between MCP-1 uptake and the number of lesion macrophages was observed (r 5 0.87; P , 0.0001) ( ½Fig: 4 Fig. 4 ). There was a statistically insignificant negative correlation of MCP-1 with the SMC prevalence in the atherosclerotic lesions. The staining for MCP-1 colocalized with the macrophages; the MCP-1 antibody reacts with both radiolabeled MCP-1 administered exogenously and endogenous MCP-1.
DISCUSSION
The present study demonstrates the feasibility of noninvasive imaging of plaque inflammation with 99m Tc-labeled MCP-1 in a diet-injury rabbit model of atherosclerosis. A 4-fold higher uptake of radiolabeled MCP-1 was observed in the lesion as compared with that of the unaffected areas of the aorta. There was direct correlation between the magnitude of MCP-1 uptake and the extent of inflammation in the neointima. MCP-1 clearly colocalized with macrophage distribution. However, there was no apparent correlation between the subintimal SMC population and MCP-1. In vitro exper- jnm043463-tp n 10/16/07 iments revealed that the MCP-1 uptake occurred preferentially in the monocytes after they were converted to the macrophage phenotype in culture. The number of chemotactic receptors on the surface of monocytes is upregulated from about 3,000 per cell in the resting state to .60,000 per cell by activation through MCP-1 (27) . In fact, only a 20% increase of CCR-2 receptors on the cell surface doubles the chemotactic response of THP-1 cells to MCP-1 (28, 29) . MCP-1 has an affinity of about 10 29 M for the CCR-2 chemokine receptor (30) . Upregulation of the CCR-2 receptor on monocytes in response to a higher circulating MCP-1 level has been demonstrated. CCR-2 receptors are expressed predominantly at the cell surface of activated monocytes and offer substrate for easy targeting by appropriately labeled exogenous targeting agents (30) .
125 I-Labeled MCP-1 has been used previously for the identification of lesional monocytes and macrophages in experimental atherosclerosis by autoradiography (31) . The highest 125 I-MCP uptake was observed in lesions with the higher macrophage infiltration, and there was a direct relationship between the number of RAM-11-positive macrophages per high-power field and the uptake of iodinated MCP-1. The present study describes incrementally the feasibility of noninvasive detection of increased MCP-1 uptake in the atherosclerotic lesions.
Expression of both MCP-1 and its monocyte receptor is upregulated early during the process of atherosclerotic lesion formation and persists into the advanced atherosclerotic state. Overexpression of MCP-1 in apolipoprotein E-deficient mice is known to result in accelerated atherogenesis through an increased number of macrophages and lipid accumulation in the lesion (9) . On the other hand, LDL receptor-deficient mice with deletion of the MCP-1 gene develop resistance to the effects of a cholesterol-rich diet with substantial reduction in the extent of atherosclerosis (32) , and CCR-2 receptor-deficient mice do not develop atherosclerosis (33) . Furthermore, a close association between circulating MCP-1 and other markers of atherosclerosis in humans (34) has been observed in clinical biomarker studies, which support the previous belief that MCP-1 is involved in the initiation and progression of coronary atherosclerosis.
Various radionuclide imaging approaches have been investigated to identify the inflammatory component of the atherosclerotic lesions. Although radiolabeled autologous leukocytes were first reported in the imaging of atherosclerotic lesions (35) , 18 F-FDG has been used most commonly (36) (37) (38) (39) (40) . 18 F-FDG is avidly taken up by cells with high metabolic activity and accumulates in macrophages in atherosclerotic vascular lesions. 18 F-FDG uptake in clinical carotid vascular disease has been shown to correlate with the extent of macrophage infiltration in carotid endarterectomy specimens (39) and resolves with statin treatment (37) . 18 F-FDG uptake, representative of plaque inflammation, is also higher in patients with the metabolic syndrome (38) . On the other hand, radiolabeled IgG, and its Fc fragments (41) , have been used to target Fc scavenger g-receptors expressed by macrophages. The expression of receptors for chemotactic protein (30, 31) adhesion molecules (42, 43) may offer alternative targets for imaging. Furthermore, macrophages undergoing apoptosis have been successfully targeted with radiolabeled annexin A5 (22, 44) . It is, therefore, possible to use multiple strategies for assessment of the extent of inflammation in atherosclerotic lesions. Prospective studies would be needed for defining the role of imaging inflammation in clinical practice. Because the extent of inflammation is closely linked to plaque instability, its noninvasive detection may be of clinical significance.
CONCLUSION
Noninvasive detection of inflammation in experimental atherosclerotic lesions is feasible using radiolabeled MCP-1. The uptake of MCP-1 correlated with the pathologically verified extent of macrophage infiltration in the plaque.
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